tm logo
SANGAMO THERAPEUTICS
Live/Pending
FOURTH EXTENSION - GRANTED

granted

on 22 Feb 2024

Last Applicant/ Owned by

7000 Marina Blvd

Brisbane

CA

94005

Serial Number

90420110 filed on 28th Dec 2020

Registration Number

N/A

Correspondent Address

R. Gwen Peterson

KILPATRICK TOWNSEND & STOCKTON LLP

2175 NORTH CALIFORNIA BOULEVARD

SUITE 600

WALNUT CREEK,CA 94596

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"THERAPEUTICS"

SANGAMO THERAPEUTICS

Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in Read More

Classification Information


Class [045]
Personal & Legal & Social Services


Licensing of intellectual property rights

Class [042]
Computer & Software Services & Scientific Services


Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing

Class [005]
Pharmaceutical Products


Biochemicals, biologics, and pharmaceutical preparations, namely, reagents in the nature of engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for clinical medical use and medical use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; Reagents, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical medical use and medical use

Class [001]
Chemical Products


Biochemicals and biologics, namely, engineered proteins in raw material form for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, medical pharmaceutical research, scientific agricultural biotechnology research, medical diagnostics research, industrial scientific biotechnology research and all for clinical medical laboratory use and medical laboratory use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; engineered proteins in raw material form for use in scientific research and analysis relating to genetic diseases, gene therapy, cell therapy, genome editing, and genome regulation; biochemicals and biologics, namely, reagents in the nature of engineered nucleic acids for laboratory use, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins in raw material form for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research, analysis and diagnostics and all for medical clinical laboratory use and medical laboratory use

Mark Details


Serial Number

No 90420110

Mark Type

No Service Mark

Attorney Docket Number

No 1225327

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

02.01.33 -

Grotesque men formed by letters, numbers, punctuation or geometric shapes

02.03.26 -

Grotesque women formed by letters, numbers, punctuation or geometric shapes

26.01.04 -

Circles with two breaks or divided in the middle

26.01.17 -

Two concentric circles

26.01.21 -

Circles that are totally or partially shaded

26.17.06 -

Diagonal line(s), band(s) or bar(s)

Description of Design Search

The mark consists of the wording "SANGAMO" in a stylized font with the letter "O" in "SANGAMO" comprised of two concentric circles with the outer circle being broken by two diagonal lines and the word "THERAPEUTICS" in a stylized font is centered below the letters "AMO" in the wording "SANGAMO".

Legal History


Show more

Status DateAction Taken
23rd Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Feb 2024SOU TEAS EXTENSION RECEIVED
22nd Feb 2024SOU EXTENSION 4 FILED
22nd Feb 2024SOU EXTENSION 4 GRANTED
22nd Aug 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18th Aug 2023SOU TEAS EXTENSION RECEIVED
18th Aug 2023SOU EXTENSION 3 FILED
18th Aug 2023SOU EXTENSION 3 GRANTED
22nd Feb 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20th Feb 2023SOU TEAS EXTENSION RECEIVED